Outcomes of Peginterferon Alpha-2a and Ribavirin Hepatitis C therapy in Aboriginal Canadians

Outcomes of Peginterferon Alpha-2a and Ribavirin Hepatitis C therapy in Aboriginal Canadians

BACKGROUND: There is little published information on baseline characteristics and therapeutic outcomes in hepatitis C virus (HCV)-infected Aboriginal Canadians. It is unclear what proportion of HCV-infected Aboriginal people receive therapy relative to other populations.

Bibliographic Details
Main Authors: Curtis L Cooper, Robert J Bailey, Vince G Bain, Frank Anderson, Eric M Yoshida, Mel Krajden, Paul Marotta, for the Canadian Pegasys Study Group
Format: Article
Language:English
Published: Hindawi Limited 2008-01-01
Series:Canadian Journal of Gastroenterology
Online Access:http://dx.doi.org/10.1155/2008/320150
id doaj-36c5a9bb10b1431f9caa1aaedc331f0f
record_format Article
spelling doaj-36c5a9bb10b1431f9caa1aaedc331f0f2020-11-24T22:37:15ZengHindawi LimitedCanadian Journal of Gastroenterology0835-79002008-01-0122867768010.1155/2008/320150Outcomes of Peginterferon Alpha-2a and Ribavirin Hepatitis C therapy in Aboriginal CanadiansCurtis L Cooper0Robert J Bailey1Vince G Bain2Frank Anderson3Eric M Yoshida4Mel Krajden5Paul Marotta6for the Canadian Pegasys Study GroupUniversity of Ottawa, Ottawa, Ontario, CanadaRoyal Alexandra Hospital, CanadaUniversity of Alberta, Edmonton, Alberta, CanadaThe Liver and Intestinal Research Centre, CanadaVancouver Hospital Health Sciences Centre, CanadaBC Centre for Disease Control, Vancouver, British Columbia, CanadaUniversity of Western Ontario, London, Ontario, CanadaBACKGROUND: There is little published information on baseline characteristics and therapeutic outcomes in hepatitis C virus (HCV)-infected Aboriginal Canadians. It is unclear what proportion of HCV-infected Aboriginal people receive therapy relative to other populations.http://dx.doi.org/10.1155/2008/320150
collection DOAJ
language English
format Article
sources DOAJ
author Curtis L Cooper
Robert J Bailey
Vince G Bain
Frank Anderson
Eric M Yoshida
Mel Krajden
Paul Marotta
for the Canadian Pegasys Study Group
spellingShingle Curtis L Cooper
Robert J Bailey
Vince G Bain
Frank Anderson
Eric M Yoshida
Mel Krajden
Paul Marotta
for the Canadian Pegasys Study Group
Outcomes of Peginterferon Alpha-2a and Ribavirin Hepatitis C therapy in Aboriginal Canadians
Canadian Journal of Gastroenterology
author_facet Curtis L Cooper
Robert J Bailey
Vince G Bain
Frank Anderson
Eric M Yoshida
Mel Krajden
Paul Marotta
for the Canadian Pegasys Study Group
author_sort Curtis L Cooper
title Outcomes of Peginterferon Alpha-2a and Ribavirin Hepatitis C therapy in Aboriginal Canadians
title_short Outcomes of Peginterferon Alpha-2a and Ribavirin Hepatitis C therapy in Aboriginal Canadians
title_full Outcomes of Peginterferon Alpha-2a and Ribavirin Hepatitis C therapy in Aboriginal Canadians
title_fullStr Outcomes of Peginterferon Alpha-2a and Ribavirin Hepatitis C therapy in Aboriginal Canadians
title_full_unstemmed Outcomes of Peginterferon Alpha-2a and Ribavirin Hepatitis C therapy in Aboriginal Canadians
title_sort outcomes of peginterferon alpha-2a and ribavirin hepatitis c therapy in aboriginal canadians
publisher Hindawi Limited
series Canadian Journal of Gastroenterology
issn 0835-7900
publishDate 2008-01-01
description BACKGROUND: There is little published information on baseline characteristics and therapeutic outcomes in hepatitis C virus (HCV)-infected Aboriginal Canadians. It is unclear what proportion of HCV-infected Aboriginal people receive therapy relative to other populations.
url http://dx.doi.org/10.1155/2008/320150
work_keys_str_mv AT curtislcooper outcomesofpeginterferonalpha2aandribavirinhepatitisctherapyinaboriginalcanadians
AT robertjbailey outcomesofpeginterferonalpha2aandribavirinhepatitisctherapyinaboriginalcanadians
AT vincegbain outcomesofpeginterferonalpha2aandribavirinhepatitisctherapyinaboriginalcanadians
AT frankanderson outcomesofpeginterferonalpha2aandribavirinhepatitisctherapyinaboriginalcanadians
AT ericmyoshida outcomesofpeginterferonalpha2aandribavirinhepatitisctherapyinaboriginalcanadians
AT melkrajden outcomesofpeginterferonalpha2aandribavirinhepatitisctherapyinaboriginalcanadians
AT paulmarotta outcomesofpeginterferonalpha2aandribavirinhepatitisctherapyinaboriginalcanadians
AT forthecanadianpegasysstudygroup outcomesofpeginterferonalpha2aandribavirinhepatitisctherapyinaboriginalcanadians
_version_ 1725718137968525312

Similar Items